Melanie Hughes, PA
Physician Assistant · Longview, WANPI 1386151504
Payments from drug & device makers
Across 59 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$237
- Astellas Pharma US Inc$137
- Amgen$117
- Daiichi Sankyo Inc.$82
- AbbVie$80
- AstraZeneca$68
- plus $509 from 14 others
What the payments were for
- Food & beverage$1,11491%
- Education$1169%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $237 |
| Astellas Pharma US Inc | 3 | $137 |
| Amgen | 5 | $117 |
| Daiichi Sankyo Inc. | 4 | $82 |
| AbbVie | 4 | $80 |
| AstraZeneca | 3 | $68 |
| Lilly USA, LLC | 3 | $66 |
| Pfizer | 2 | $55 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Boehringer Ingelheim | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| GSK | 2 | $28 |
| Grifols USA, LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
How this compares
$1,230 in reported general payments places this provider in the 85th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $28,707 |
| Rosuvastatin Calcium | 41 | $1,278 |
| Atorvastatin Calcium | 103 | $824 |
| Levothyroxine Sodium | 66 | $727 |
| Metoprolol Succinate | 18 | $550 |
| Omeprazole | 30 | $504 |
| Escitalopram Oxalate | 22 | $456 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $403 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $382 |
| Bupropion XlBupropion Hcl | 17 | $367 |
| Amlodipine Besylate | 54 | $362 |
| Gabapentin | 28 | $325 |
| Lisinopril | 56 | $292 |
| Buspirone Hcl | 11 | $274 |
| Oxycodone Hcl | 16 | $266 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Longview
- Adam CherryLongview$15K
- Rachel RoylanceLongview$11K
- Nicholas AustinLongview$8K
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.